These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8824364)

  • 21. Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study.
    Mohr BA; Feldman HA; Kalish LA; Longcope C; McKinlay JB
    Urology; 2001 May; 57(5):930-5. PubMed ID: 11337297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and urinary androgens and risk of breast cancer in postmenopausal women.
    Secreto G; Toniolo P; Berrino F; Recchione C; Cavalleri A; Pisani P; Totis A; Fariselli G; Di Pietro S
    Cancer Res; 1991 May; 51(10):2572-6. PubMed ID: 2021938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower Circulating Androgens Are Associated with Overall Cancer Risk and Prostate Cancer Risk in Men Aged 25-84 Years from the Busselton Health Study.
    Chan YX; Knuiman MW; Divitini ML; Handelsman DJ; Beilby JP; Yeap BB
    Horm Cancer; 2018 Dec; 9(6):391-398. PubMed ID: 30097782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasectomy and prostate cancer: results from a multiethnic case-control study.
    John EM; Whittemore AS; Wu AH; Kolonel LN; Hislop TG; Howe GR; West DW; Hankin J; Dreon DM; Teh CZ
    J Natl Cancer Inst; 1995 May; 87(9):662-9. PubMed ID: 7538594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do differences in age specific androgenic steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians?
    Kehinde EO; Akanji AO; Al-Hunayan A; Memon A; Luqmani Y; Al-Awadi KA; Varghese R; Bashir AA; Daar AS
    Int J Urol; 2006 Apr; 13(4):354-61. PubMed ID: 16734850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study.
    Trabert B; Michels KA; Anderson GL; Brinton LA; Falk RT; Geczik AM; Harris HR; Pan K; Pfeiffer RM; Qi L; Rohan T; Wentzensen N; Xu X
    Int J Cancer; 2019 Oct; 145(8):2051-2060. PubMed ID: 30684389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States).
    Nomura AM; Stemmermann GN; Lee J; Kolonel LN; Chen TC; Turner A; Holick MF
    Cancer Causes Control; 1998 Aug; 9(4):425-32. PubMed ID: 9794175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum androgens: associations with prostate cancer risk and hair patterning.
    Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
    J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
    Int J Cancer; 2004 Jan; 108(3):418-24. PubMed ID: 14648709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediagnostic serum hormones and the risk of prostate cancer.
    Nomura A; Heilbrun LK; Stemmermann GN; Judd HL
    Cancer Res; 1988 Jun; 48(12):3515-7. PubMed ID: 3370644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.
    Meyer TE; Chu LW; Li Q; Yu K; Rosenberg PS; Menashe I; Chokkalingam AP; Quraishi SM; Huang WY; Weiss JM; Kaaks R; Hayes RB; Chanock SJ; Hsing AW
    Prostate; 2012 Jan; 72(1):65-71. PubMed ID: 21520164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada.
    Whittemore AS; Wu AH; Kolonel LN; John EM; Gallagher RP; Howe GR; West DW; Teh CZ; Stamey T
    Am J Epidemiol; 1995 Apr; 141(8):732-40. PubMed ID: 7535977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal predictors of prostate cancer: a meta-analysis.
    Shaneyfelt T; Husein R; Bubley G; Mantzoros CS
    J Clin Oncol; 2000 Feb; 18(4):847-53. PubMed ID: 10673527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects.
    Santner SJ; Albertson B; Zhang GY; Zhang GH; Santulli M; Wang C; Demers LM; Shackleton C; Santen RJ
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2104-9. PubMed ID: 9626146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.
    Graff RE; Meisner A; Ahearn TU; Fiorentino M; Loda M; Giovannucci EL; Mucci LA; Pettersson A
    Br J Cancer; 2016 Apr; 114(8):939-44. PubMed ID: 26986253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
    Hayes VM; Severi G; Padilla EJ; Morris HA; Tilley WD; Southey MC; English DR; Sutherland RL; Hopper JL; Boyle P; Giles GG
    Int J Cancer; 2007 Feb; 120(4):776-80. PubMed ID: 17136762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.
    Gershman B; Shui IM; Stampfer M; Platz EA; Gann PH; Sesso HL; DuPre N; Giovannucci E; Mucci LA
    Eur Urol; 2014 Apr; 65(4):683-9. PubMed ID: 23340241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.
    Wu AH; Whittemore AS; Kolonel LN; Stanczyk FZ; John EM; Gallagher RP; West DW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):533-8. PubMed ID: 11352865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.
    Dorgan JF; Albanes D; Virtamo J; Heinonen OP; Chandler DW; Galmarini M; McShane LM; Barrett MJ; Tangrea J; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1069-74. PubMed ID: 9865423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.